gdb I would agree with you on most points here however the fact that they may have actually completed a deal with Invensys does give some reason to be a little optimistic. The Transcore deal at this point doesn't look so likely and I think the market has already factored this in. From Transcore's announcement it looks like the labels have already been completed and ready for sale, so logic says they are not using Mikoh's technology but maybe there remains some room for last minute negotiations?? Or its possible that they could still switch to use Mikoh at any point even if they are using an alternative technology now. So while it may rule out a deal now it does not have to rule out a deal at some later stage.Or may be its none of the above reasons and I haven't got a clue. The US trials appear to be going well into overtime and a result must be due soon? Again the market seems to be factoring in a negative result here.
MIK Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
